"...would another company want to sign up for a DIC deal?"
I think a concern should be why LEO isn't all over ATRYN if it actually works in the PII DIC trial? Without DIC efficacy, which is already way behind schedule, the ultimate value of GTC is significantly less, imo.
"One word sums up probably the responsibility of any vice
president, and that one word is 'to be prepared.'" - Dan
Quayle